A recombinant peptide model of the first nucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator: Comparison of wild-type and ΔF508 mutant forms

Protein Science

Volumn 5, Issue 1, 1996, Pages 89-97

  Yike, Iwona ^a   Ye, Jin ^a   Zhang, Yan ^a   Manavalan, Parthasarathy ^b   Gerken, Thomas A ^a   Dearborn, Dorr G ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENZYME CORPORATION   (United States)

Author keywords

autologous folding; cystic fibrosis; mutation; nucleotide binding protein

Indexed keywords

MUTANT PROTEIN; RECOMBINANT PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CYSTIC FIBROSIS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING;

BACTERIA (MICROORGANISMS);

EID: 0030033151     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560050111     Document Type: Article

References (54)

1. Ames GFL, Lecar H. 1992. ATP-dependent bacterial transports and cystic fibrosis: Analogy between channels and transporters. FASEB J 6:2660-2666.
2. Anderson MP, Welsh MJ. 1992. Regulation by ATP and ADP of CFTR chloride channels in the apical membrane of normal and cystic fibrosis airway and intestinal epithelia. Science 257:1701-1704.
3. Bear CE, Li C, Kartner N, Bridges RJ, Jensen TJ, Ramjeesingh M, Riordan JR. 1992. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator. Cell 68:809-818.
4. Carson M, Welsh M. 1993. 5′-Adenylylimidodiphosphate does not activate CFTR chloride channels in cell-free patches of membrane. Am J Physiol 265:L27-L32.
5. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE. 1990. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63: 827-834.
6. Chou PY, Fasman GD. 1978. Prediction of secondary structure of proteins from their amino acid sequence. Adv Enzymol 47:45-148.
7. Dalemans W, Barbry P, Champigny G, Jallat S, Dott K, Dreyer D, Crystal RG, Pavirani A, Lecoq JP, Lazdunski M. 1991. Altered chloride ion channel kinetics associated with ΔF508 cystic fibrosis mutation. Nature 354:526-528.
8. Denning G, Anderson M, Amara J, Marshall J, Smith A, Welsh M. 1992. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358:761-764.
9. Dulhanty AM, Riordan JR. 1994. A two-domain model for the R domain of the cystic fibrosis transmembrane conductance regulator based on sequence similarities. FEBS Lett 343:109-114.
10. Fung BKK, Nash CR. 1983. Characterization of transducin from bovine rod outer segments. II. Evidence for distinct binding sites and conformational changes revealed by limited proteolysis with trypsin. Biochemistry 258: 10503-10510.
11. Garnier J, Osguthorpe DJ, Robson B. 1978. Analysis of the accuracy and implications of simple method for predicting the secondary structure of globular proteins. J Mol Biol 120:97-120.
12. Gill SC, von Hippel PH. 1989. Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem 182:319-326.
13. Gregory RJ, Cheng SH, Rich DP, Marshall J, Paul S, Hehir K, Ostedgaard L, Klinger KW, Welsh MJ, Smith AE. 1990. Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature 347:382-386.
14. Gunderson KL, Kopito RR. 1994. Effects of pyrophosphate and nucleotide analogs suggest a role for ATP hydrolysis in cystic fibrosis transmembrane regulator gating. J Biol Chem 269:19349-19353.
15. Hartman J, Huang Z, Rado TA, Peng S, Jilting T, Muccio DD, Sorsher EJ. 1992. Recombinant synthesis, purification, and nucleotide binding characteristics of the first nucleotide binding domain of the cystic fibrosis gene product. J Biol Chem 267:6455-6458.
16. Hennessey JP Jr, Johnson WC Jr. 1981. Information content in the circular dichroism of proteins. Biochemistry 20:1085-1094.
17. o. J Biol Chem 262:757-761.
18. Hwang TC, Nagel G, Nairn AC, Gadsby DC. 1994. Regulation of the gating of cystic fibrosis transmembrane conductance regulator Cl channels by phosphorylation and ATP hydrolysis. Proc Natl Acad Sci USA 91: 4698-4702.
19. Hyde SC, Emsley P, Hartshorn MJ, Mimmack MM, Gileadi U, Pearce SR, Gallagher MP, Gill DR, Hubbard RE, Higgins CF. 1990. Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 346:362-365.
20. John J, Sohmen R, Feuerstein J, Linke R, Wittinghofer A, Goody R. 1990. Kinetics of interactions of nucleotides with nucleotide-free H-ras 21. Biochemistry 29:6058-6065.
21. Johnson KA. 1992. Transient-state kinetic analysis of enzyme reaction pathways. In: Sigman, DS. The enzymes, 3rd ed, vol XX. New York: Academic Press. pp 2-62.
22. Kartner N, Augustinas O, Jensen TJ, Naismith AL, Riordan JR. 1992. Mislocalization of ΔF508 CFTR in cystic fibrosis sweat gland. Nature Genet 1:321-327.
23. Ko Y, Pedersen P. 1995. The first nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator can function as a active ATPase. J Biol Chem 270:22093-22096.
24. Ko Y, Thomas P, Delannoy M, Pedersen P. 1993. The cystic fibrosis transmembrane conductance regulator. Overexpression, purification, and characterization of wild type and ΔF508 mutant forms of the first nucleotide binding fold in fusion with the maltose-binding protein. J Biol Chem 268:24330-24338.
25. Kyte J, Doolittle RF. 1982. A simple method for displaying the hydropathic character of a protein. J Mol Biol 157:105-132.
26. Laemmli IK. 1970. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680-685.
27. Larsen M, Willett R, Yount R. 1969. Imidodiphosphate and pyrophosphate: Possible biological significance of similar structures. Science 166:1510.
28. Li C, Ramjeesingh M, Reyes E, Jensen T, Chang X, Rommens J, Bear CE. 1993. The cystic fibrosis mutation ΔF508 does not influence the chloride channel activity of CFTR. Nature Genet 3:311-316.
29. Logan J, Hiestand D, Daram P, Huang Z, Muccio DD, Hartman J, Haley B, Cook WJ, Sorscher EJ. 1994. Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding. J Clin Invest 94:228-236.
30. Logan J, Huang Z, Peng S, Hartman J, Jilling T, Kirk K, Lebowitz J, Murti G, Muccio D, Sorscher E. 1992. Purification and characterization of the first nucleotide binding domain of CFTR. Pediat Pulmonol(Suppl 8). [Abstr #103].
31. Manavalan P, Dearborn DG, McPherson JM, Smith AE. 1995. Sequence homologies between nucleotide binding regions of CFTR and G-proteins suggest structural and functional similarities. FEBS Lett 366:87-91.
32. Manavalan P, Johnson WC Jr. 1987. Variable selection method improves the prediction of protein secondary structure from circular dichroism data. Anal Biochem 167:76-85.
33. Milburn MV, Tong L, DeVos AM, Brunger A, Yamaizumi Z, Nishimura S, Kim SH. 1990. Molecular switch for signal transduction: Structural differences between active and inactive forms of protooncogenic ras proteins. Science 247:939-945.
34. Mimura CS, Holbrook SR, Ames GFL. 1991. Structural model of the nucleotide-binding conserved component of periplasmic permeases. Proc Natl Acad Sci USA 88:84-88.
35. 2+ -ATPase overexpressed in E. coli. J Biol Chem 269:11147-11154.
36. Mullen GP, Shenbagamurthi P, Mildvan AS. 1989. Substrate and DNA binding to a 50-residue peptide fragment of DNA polymerase I. J Biol Chem 264:19637-19647.
37. Quinton PM, Reddy MM. 1992. Control of CFTR chloride conductance by ATP levels through non-hydrolytic binding. Nature 360:79-81.
38. Randak C, Roscher AA, Hadorn HB, Assfalg-Machleidt I, Auerswald EA, Machleidt W. 1995. Expression and functional properties of the second predicted nucleotide binding fold of the cystic fibrosis transmembrane conductance regulator fused to glutathione-S-transferase. FEBS Lett 363:189-194.
39. Rich DP, Gregory RJ, Cheng S, Smith AE, Welsh MJ. 1993. Effect of deletion mutations on the function of CFTR chloride channels. Receptors and Channels 1:221-232.
40. Riordan JR. 1993. The cystic fibrosis transmembrane conductance regulator. Annu Rev Physiol 55:609-630.
41. Riordan JR, Rommens JM, Kerem BS, Alom N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui LC. 1989. Identification of the cystic fibrosis gene: Cloning and characterization of the complementary DNA. Science 245:1066-1073.
42. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: A laboratory manual, 2nd ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press.
43. - channel gating by ADP and ATP analogues. J Gen Physiol 105:329-361.
44. Sheppard DN, Ostedgaard LS, Rich DP, Welsh MJ. 1994. The amino-terminal portion of CFTR forms a regulated chloride channel. Cell 76:1091-1098.
45. Thomas PJ, Ko YH, Pedersen PL. 1992a. Altered protein folding may be the molecular basis of most cases of cystic fibrosis. FEBS Letters 312:7-9.
46. Thomas PJ, Pedersen PL. 1993. Effects of the ΔF508 mutation on the structure, function, and folding of the first nucleotide-binding domain of CFTR. J Bioeng Biomembr 25:11-19.
47. Thomas PJ, Shenbagamurthi P, Sondek J, Hullihen JM, Pedersen PL. 1992b. The cystic fibrosis transmembrane conductance regulator. Effects of the most common cystic fibrosis-causing mutation on the secondary structure and stability of a synthetic peptide. J Biol Chem 267:5727-5730.
48. Travis S, Carson M, Ries D, Welsh M. 1993. Interactions of nucleotides with membrane-associated cystic fibrosis transmembrane conductance regulator. J Biol Chem 268:15336-15339.
49. Tsui LC. 1992. The spectrum of cystic fibrosis mutations. Trends Genetics 8:392-398.
50. Venglarik CJ, Schultz BD, Frizzell RA, Bridges RJ. 1994. ATP alters current fluctuations of cystic fibrosis transmembrane conductance regulator: Evidence for a three state gating mechanism. J Gen Physiol 104: 123-146.
51. Walker JE, Savaste M, Runswick MJ, Gay NJ. 1982. Distantly related sequences in the α- and β-subunits of ATP synthetase, myosin, kinases, and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J 1:945-951.
52. Welsh MJ, Smith AE. 1993. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 73:1251-1254.
53. a(EIIA): Oncogene dependent regulation. Experimental Cell Research 213:253-265.
54. Yike I, Zhang Y, Ye J, Dearborn DG. 1996. Expression in E. coli of cytoplasmic portions of the cystic fibrosis transmembrane conductance regulator: Apparent bacterial toxicity of peptides containing R domain sequences. Protein Express Purific. Forthcoming.